Researchers at MU and MURR develop potential cancer agents

A new study by researchers at MU and MURR advances development of theranostic pairs for potential diagnosis and treatment of cancer.

In the ongoing fight against cancer, researchers are exploring pairs of radioactive isotopes for imaging and treating tumors. Known as “theranostic pairs,” one isotope can help clinicians diagnose and image tumors in the body while the other delivers a therapeutic punch to the tumor itself.

In a recent study published by ScienceDirect, researchers at MU and MURR synthesized novel peptides for the imaging and treatment of neuroendocrine tumors (NETs) using technetium—99m as the diagnostic component and rhenium-186 as the therapeutic component. The study showed promising results for the technetium complex and future studies will determine the potential for translating the design into clinical use.

To read more about this exciting research, click here.